Welcome to CD Formulation
Products
Voglibose
Product Details
Molecular Formula
C10H21NO7
Molecular Weight
267.28
Appearance
Solid
Grade
Pharmaceutical grade
Standard
USP
Description
Voglibose is a potent synthetic compound classified as an alpha-glucosidase inhibitor, characterized chemically as a valiolamine derivative. As the active pharmaceutical substance, it is a white crystalline powder that serves as the essential core component in the final formulated anti-diabetic medication, functioning by specifically and reversibly inhibiting carbohydrate-digesting enzymes in the small intestine.
CAS Number
83480-29-9
Stability and Storage Conditions
Hygroscopic
Solubility
DMSO (Slightly), Methanol (Very Slightly, Heated)
Storage
-20°C
Boiling Point
601.9±55.0 °C(Predicted)
Melting Point
162-163°C
Density
1.58±0.1 g/cm3(Predicted)
Applications
The primary therapeutic application of Voglibose is in the manufacture of finished dosage forms (primarily tablets) for the management of type 2 diabetes mellitus. It is specifically formulated to control postprandial hyperglycemia, and its use as an API is mandated in producing drugs that function as an adjunct to diet and exercise, either as monotherapy or in combination with other anti-diabetic agents.
Color
White to Off-White
MDL number
MFCD00865496
SMILES
O[C@@H]1[C@@H](O)[C@H](O)[C@H](NC(CO)CO)C[C@]1(CO)O
InChI
InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m1/s1
Water Solubility
Water (Sparingly, Sonicated)
InChI Key
FZNCGRZWXLXZSZ-CIQUZCHMSA-N
WGK Germany
3
RTECS
NM7524600
Online Inquiry
Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.
GET IN TOUCH
Enter your email here to subscribe.
Easy access to products and services you need from our library via powerful searching tools.